Celldex Therapeutics, Inc. (CLDX)

NASDAQ: CLDX · USD

$29.6

-0.56 (-1.9%)· Recorded snapshot

Market cap	2.3B
Revenue (ttm)	158K
Net income (ttm)	-300.5M
EPS (ttm)	-$4.33
Shares out	78.5M
Volume	707,912
Beta	0.90

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 158K
Net income (ttm): -300.5M
EPS (ttm): -$4.33
Market cap: 2.3B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantener

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-43.9

P25 n/aP50 n/aP75 n/a

ROIC-29.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All CLDX indicators

Market & fundamental data

Available fields

203

Groups with data

Currency

USD

Showing 203 of 203 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0000744218
Company name	Celldex Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	15117B202
Earnings date	2026-11-09
Earnings time	amc
Employees	198
Employees change	12
Employees growth	6.45%
Enterprise value	$1.6B
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2008-03-10
Is primary listing	Yes
Is SPAC	No
ISIN number	US15117B2025
Last 10-K release date	2026-02-25
Last earnings date	2026-08-06
Last refreshed	2026-10-28
Last stock split date	2019-02-11
Last stock split type	Reverse
Market cap	$2.3B
Market cap category	Mid-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$29.59
Price currency	USD
Sector	Healthcare
SIC code	2835
Stock price date	2026-10-28
Symbol	CLDX
U.S. state	New Jersey
Website	https://www.celldex.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-14.65%
EV/Sales	10,146.54x
FCF / EV yield	-15.1%
FCF yield	-10.45%
Forward EV/Sales	606.8x
Forward P/S	876.55x
P/B ratio	3.31x
P/S ratio	14,657.19x
Price / tangible book value	3.37x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Operating margin	-206,220.25%
Pretax margin	-190,220.89%
Profit per employee	$-1.5M
Revenue per employee	$798
ROA	-27.62%
ROA (5Y)	-19.34%
ROCE	-45.19%
ROE	-43.88%
ROE (5Y)	-31.49%
ROIC	-29.56%
SBC / revenue	21,924.68%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth	-97.27%
Revenue growth (Q)	-96.99%
Revenue growth (QoQ)	46.67%
Revenue growth 10Y	-29.89%
Revenue growth 3Y	-63.52%
Revenue growth 5Y	-55.06%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-6.5M
Depreciation and amortization	$3.4M
EBIT	$-325.8M
EBITDA	$-322.4M
EPS	$-4.33
FCF per share	$-3.08
Financing cash flow	$327.1M
Free cash flow	$-242.1M
Free cash flow minus SBC	$-276.7M
Gross profit	$-278.6M
Investing cash flow	$-67.1M
Net cash flow	$24.4M
Net income	$-300.5M
Operating cash flow minus SBC	$-270.2M
Operating income	$-325.8M
Revenue	$158,000
Stock-based compensation	$34.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	12.97
Book value per share	$9.10
Debt / equity	0.01
Long-term assets	$57.4M
Long-term liabilities	$6.5M
Net cash (debt)	$712.7M
Net cash / market cap	30.77%
Net cash growth	13.61%
Net debt / equity	-1
Piotroski F-Score	1
Property, plant and equipment	$14.8M
Shareholders' equity	$714.6M
Tangible book value	$687.4M
Tangible book value per share	$8.76
Total assets	$782.3M
Total cash	$717.6M
Total debt	$4.9M
Total liabilities	$67.8M
WACC	9.16%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0
Current assets	$724.9M
Current liabilities	$61.3M
Current ratio	11.82
Net working capital	$-52.4M
Quick ratio	11.71
Working capital	$663.6M
Working capital turnover	0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-4.49%
Dividend yield	0%
Shareholder yield	-4.49%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-39.48%
10Y return CAGR	-4.9%
10Y total return	-39.48%
150-day SMA	$34.46
15Y price change	-38.34%
15Y return CAGR	-3.17%
15Y total return	-38.34%
1D price change	-1.86%
1M price change	-5.72%
1M total return	-5.72%
1W price change	-3.2%
1W total return	-3.2%
1Y price change	7.13%
1Y return CAGR	7.13%
1Y total return	7.13%
20-day SMA	$29.78
200-day SMA	$32.61
3M price change	-17.76%
3M total return	-17.76%
3Y price change	29.68%
3Y return CAGR	9.05%
3Y total return	29.68%
50-day SMA	$34.48
50-day SMA vs 200-day SMA	50over200
52-week high	$45.14
52-week high date	2026-08-12
52-week low	$22.10
52-week low date	2025-11-11
5Y price change	-34.19%
5Y return CAGR	-8.03%
5Y total return	-34.19%
6M price change	-12.89%
6M total return	-12.89%
All-time high	$582.60
All-time high date	2013-10-02
All-time low	$1.50
All-time low date	2020-03-19
Average true range (ATR)	$1.44
Average volume	1.3M
Beta (1Y)	1.28
Beta (2Y)	1.42
Beta (5Y)	0.9
Change from 52-week high	-34.45%
Change from 52-week low	33.89%
Change from all-time high	-94.97%
Change from all-time low	1,854.67%
Change from open	0.14%
Day's gap	-1.99%
Dollar volume	$20.9M
High price	$29.59
Low price	$28.96
Monthly RSI	48.5
Open price	$29.55
Position in 52-week range	100%
Premarket change	-0.66%
Premarket close	$30.15
Premarket price	$29.95
Premarket volume	4.2K
Previous close	$30.15
Price vs 150-day SMA	-14.92%
Price vs 20-day SMA	-1.53%
Price vs 200-day SMA	-10.08%
Price vs 50-day SMA	-14.97%
Relative volume	0.53
RSI	41.66
Sharpe ratio	0.31
Sharpe ratio (3Y)	0.32
Sharpe ratio (5Y)	0.05
Sortino ratio	0.61
Sortino ratio (3Y)	0.61
Sortino ratio (5Y)	0.19
Volume	707.9K
Weekly RSI	42.69
YTD price change	7.95%
YTD total return	7.95%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	73M
Float percentage	92.98%
Shares change (QoQ)	16.94%
Shares change (YoY)	4.49%
Shares held by insiders	0.24%
Shares held by institutions	110.56%
Shares outstanding	78.5M
Short % of float	15.07%
Short % of shares	14.02%
Short ratio	6 days

Deeper analysis on CLDX

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this CLDX report

Is a complete CLDX research report available?

No complete published report is available for Celldex Therapeutics, Inc. (CLDX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Celldex Therapeutics, Inc. (CLDX)

Price

Financial snapshot

Fair-value bridge

Latest news · CLDX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CLDX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on CLDX

Frequently asked questions